Published in Br J Dermatol on August 01, 2006
Advanced basal cell carcinoma. Wien Med Wochenschr (2013) 1.71
Giant epithelial malignancies (Basal cell carcinoma, squamous cell carcinoma): a series of 20 tumors from a single center. J Cutan Aesthet Surg (2012) 1.23
CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge. Eplasty (2010) 1.19
Large superficial Basal cell carcinoma arising in the scalp. Ann Dermatol (2011) 1.11
Management of superficial basal cell carcinoma: focus on imiquimod. Clin Cosmet Investig Dermatol (2009) 1.08
Relapsing advanced metatypical basal cell carcinomas (MTBCC) of the face: surgical modalities. Wien Med Wochenschr (2014) 0.91
Staged-surgery with permanent pathology for the management of high-risk nonmelanoma skin cancer of the nose. Eur Arch Otorhinolaryngol (2010) 0.89
Metastatic Basal cell carcinoma: a biological continuum of Basal cell carcinoma? Case Rep Dermatol Med (2012) 0.88
Characteristics of Mixed Type Basal Cell Carcinoma in Comparison to Other BCC Subtypes. Indian J Dermatol (2014) 0.84
Risk factors in Central Poland for the development of superficial and nodular basal cell carcinomas. Arch Med Sci (2010) 0.80
Sun-Protective Behaviors of Student Spectators at Inter-school Swimming Carnivals in a Tropical Region Experiencing High Ambient Solar Ultraviolet Radiation. Front Public Health (2016) 0.75
A clinicopathological survey of Basal cell carcinoma in an Iranian population. J Dent (Shiraz) (2013) 0.75
Superficial Basal Cell Carcinoma Treated with Two Cycles of Ingenol Mebutate Gel 0.015. Ann Dermatol (2016) 0.75
Superficial Basal Cell Carcinoma on the Face is a Diagnostic Challenge. Indian J Dermatol (2016) 0.75
Different Anatomical Distribution of Basal Cell Carcinoma Subtypes in Iranian Population: Association between Site and Subtype. Ann Dermatol (2014) 0.75
Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma. Int J Clin Exp Pathol (2015) 0.75
Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg (2010) 2.72
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer (2009) 1.93
Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol (1999) 1.79
Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer (2000) 1.79
Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol (2002) 1.71
Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma. J Clin Epidemiol (1997) 1.69
The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology (2001) 1.66
Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol (1996) 1.65
Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer (1997) 1.59
Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol (2001) 1.56
Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol (1998) 1.54
Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol (2001) 1.49
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol (2007) 1.49
Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47
[Elective lymph node dissection in primary malignant melanoma]. Hautarzt (1996) 1.39
[Merkel cell tumor of the skin]. Dtsch Med Wochenschr (1997) 1.38
Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol (1996) 1.38
Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer (2010) 1.37
Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol (2000) 1.29
Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy. J Cutan Pathol (2000) 1.27
Head lice in pupils of a primary school in Australia and implications for control. Int J Dermatol (1999) 1.26
Interferons in dermatology. J Am Acad Dermatol (1989) 1.19
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. Br J Cancer (2012) 1.19
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother (2006) 1.18
Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res (1995) 1.18
Expression of interleukin 10 in human melanoma. Br J Cancer (1994) 1.15
Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas? Br J Dermatol (2001) 1.12
Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer (1997) 1.12
Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination. Am J Epidemiol (2000) 1.10
Molecular events in melanoma development and progression. Front Biosci (1998) 1.10
Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle. Biophys J (2010) 1.08
Acute nongonococcal epididymitis. Aetiological and therapeutic aspects. Drugs (1987) 1.06
HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J Invest Dermatol (2001) 1.05
Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol (2004) 1.04
Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J Dermatol (2005) 1.02
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer (2001) 1.02
Accuracy of clinical diagnosis of skin lesions. Br J Dermatol (2008) 1.01
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. Br J Cancer (2003) 1.00
Updated meta-analysis of randomized controlled trials comparing conventional excisional haemorrhoidectomy with LigaSure for haemorrhoids. Tech Coloproctol (2008) 0.99
Intralesional rituximab for cutaneous B-cell lymphoma. Br J Dermatol (2001) 0.97
Open compared with closed haemorrhoidectomy: meta-analysis of randomized controlled trials. Tech Coloproctol (2007) 0.96
Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol (2000) 0.96
Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study. Ann Oncol (2006) 0.96
Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res (2000) 0.95
Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation. J Invest Dermatol (2001) 0.95
Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma. Melanoma Res (1997) 0.94
RNA isolation from human skin tissues for colorimetric differential display. J Biochem Biophys Methods (1998) 0.94
Why do mothers still sun their infants? J Paediatr Child Health (1999) 0.93
Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. Br J Dermatol (2004) 0.92
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG). Ann Oncol (2008) 0.91
Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Anticancer Res (1995) 0.91
K+ channels and the intracellular calcium signal in human melanoma cell proliferation. J Membr Biol (1996) 0.91
Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol (1991) 0.91
Production of cytokines by human melanoma cells and melanocytes. Recent Results Cancer Res (1995) 0.91
Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma. A case-control study of the German Central Malignant Melanoma Registry. Acta Derm Venereol (1997) 0.90
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer (1995) 0.89
Value of the clinical history for different users of dermoscopy compared with results of digital image analysis. J Eur Acad Dermatol Venereol (2004) 0.89
Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment. Spontaneous regression 8 months after discontinuing therapy. Int J Dermatol (1991) 0.89
Clinical course and prognostic factors of Merkel cell carcinoma of the skin. Br J Dermatol (2009) 0.89
Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma. Br J Dermatol (1999) 0.89
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study. Ann Oncol (2014) 0.88
[Mollusca contagiosa in HIV infection. Clinical manifestation, relation to immune status and prognostic value in 39 patients]. Hautarzt (1997) 0.88
Dermatoscopy turns histopathologist's attention to the suspicious area in melanocytic lesions. Arch Dermatol (2001) 0.88
A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type I. Br J Dermatol (1991) 0.88
Melanoma of the ear: prognostic factors and surgical strategies. Br J Dermatol (2006) 0.87
Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol (2006) 0.86
Extreme UV exposure of professional cyclists. Dermatology (2000) 0.86
Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol (2000) 0.85
Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry. Int J Cancer (1998) 0.85
Kaposi's sarcoma: a reevaluation. Recent Results Cancer Res (1995) 0.84
[The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients]. Hautarzt (1993) 0.84
Body-site distribution of melanocytic nevi in young Australian children. Arch Dermatol (1999) 0.84
An educational intervention to improve diagnosis and management of suspicious skin lesions. J Contin Educ Health Prof (2000) 0.84
Inflammatory nodules around the axilla: an uncommon localization of orf virus infection. Clin Exp Dermatol (2008) 0.84
Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro. Pigment Cell Res (1995) 0.83
Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry. Int J Cancer (1995) 0.83
Application of argon plasma coagulation in skin surgery. Dermatology (1998) 0.83
Bacillus subtilis spore film dosimeters in personal dosimetry for occupational solar ultraviolet exposure. Int Arch Occup Environ Health (2000) 0.83
A fluorometric rapid microassay to identify anti-proliferative compounds for human melanoma cells in vitro. Melanoma Res (1992) 0.82
Predictors of the use of sunscreen in dermatological patients in Central Europe. Prev Med (2000) 0.82
Is sentinel lymph node biopsy of therapeutic relevance for melanoma? Dermatology (2004) 0.81
The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions. Br J Dermatol (2003) 0.81
Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization. Br J Cancer (2000) 0.81
Proliferation and morphology of melanoma cells and benign human melanocytes under varying culture conditions. Melanoma Res (1993) 0.80
[Shave excision of melanocytic nevi of the skin: indications, technique, results]. Hautarzt (2000) 0.80
Solar UV-protective properties of textiles. Dermatology (2000) 0.80
Treatment of psoriasis with interleukin-10. J Invest Dermatol (1998) 0.80
Role of high-resolution magnetic resonance imaging for differentiating melanin-containing skin tumors. Invest Radiol (1995) 0.80
Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol (2000) 0.80
Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions--an overview. Melanoma Res (1993) 0.80
Is isolated limb perfusion of metastatic malignant melanoma of the extremity worthwhile? Eur J Cancer (1996) 0.80
[BRAF mutation detection in metastatic melanoma]. Pathologe (2012) 0.79
Hard data needed on head lice transmission. Int J Dermatol (2000) 0.79
Elective lymph node dissection in primary malignant melanoma: a matched-pair analysis. Melanoma Res (1995) 0.79
Professional risk for skin cancer development in male mountain guides--a cross-sectional study. J Eur Acad Dermatol Venereol (2009) 0.79